We're Not Worried About LTR Pharma's (ASX:LTP) Cash Burn
Oct 18
Have your own idea? Try our Stock Screener
Australian (ASX) Pharma Industry Analysis
UpdatedFeb 27, 2026
DataAggregated Company Financials
Companies26
- 7D0.4%
- 3M-19.3%
- 1Y-22.6%
- YTD-20.4%
The Pharma industry has been flat over the last week, but Starpharma Holdings has lost 8.0%. Unfortunately though, the industry is down 23% over the past 12 months. Looking forward, earnings are forecast to grow by 29% annually.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 28 Feb 2026 | AU$4.6b | AU$1.0b | -AU$184,425,654.00 | 10x | -25x | 4.5x |
| Mon, 26 Jan 2026 | AU$5.4b | AU$1.0b | -AU$199,680,775.00 | 15x | -26.9x | 5.4x |
| Wed, 24 Dec 2025 | AU$5.5b | AU$1.0b | -AU$199,680,775.00 | 14.9x | -27.6x | 5.5x |
| Fri, 21 Nov 2025 | AU$5.7b | AU$1.0b | -AU$202,211,775.00 | 14.3x | -28.1x | 5.7x |
| Sun, 19 Oct 2025 | AU$6.4b | AU$1.0b | -AU$202,211,775.00 | 15x | -31.5x | 6.4x |
| Tue, 16 Sep 2025 | AU$5.3b | AU$1.0b | -AU$202,211,775.00 | 14.5x | -26.2x | 5.3x |
| Thu, 14 Aug 2025 | AU$5.3b | AU$1.0b | -AU$210,986,150.00 | 14.7x | -25.1x | 5.2x |
| Sat, 12 Jul 2025 | AU$4.5b | AU$1.1b | -AU$225,511,927.00 | 14.1x | -19.8x | 4.2x |
| Mon, 09 Jun 2025 | AU$4.5b | AU$1.1b | -AU$225,511,927.00 | 12.6x | -20x | 4.3x |
| Wed, 07 May 2025 | AU$4.7b | AU$1.0b | -AU$238,266,485.00 | 17.4x | -19.7x | 4.5x |
| Fri, 04 Apr 2025 | AU$4.3b | AU$1.1b | -AU$289,508,485.00 | 17.9x | -14.7x | 4x |
| Sun, 02 Mar 2025 | AU$5.4b | AU$1.1b | -AU$345,572,525.00 | 18.5x | -15.7x | 5.2x |
| Tue, 28 Jan 2025 | AU$5.6b | AU$1.0b | -AU$378,981,112.00 | 12.5x | -14.7x | 5.5x |
| Thu, 26 Dec 2024 | AU$5.1b | AU$1.0b | -AU$378,981,112.00 | 11.9x | -13.4x | 5x |
| Sat, 23 Nov 2024 | AU$5.7b | AU$1.0b | -AU$377,703,112.00 | 13x | -15x | 5.6x |
| Mon, 21 Oct 2024 | AU$6.3b | AU$1.0b | -AU$377,703,112.00 | 13.9x | -16.6x | 6.2x |
| Wed, 18 Sep 2024 | AU$6.4b | AU$1.0b | -AU$365,958,403.00 | 13.2x | -17.6x | 6.4x |
| Fri, 16 Aug 2024 | AU$6.2b | AU$995.3m | -AU$387,920,108.00 | 10.5x | -16.1x | 6.3x |
| Sun, 14 Jul 2024 | AU$6.8b | AU$995.3m | -AU$387,920,108.00 | 11.5x | -17.5x | 6.8x |
| Tue, 11 Jun 2024 | AU$6.3b | AU$1.2b | -AU$379,935,217.00 | 14.1x | -16.7x | 5.2x |
| Thu, 09 May 2024 | AU$6.2b | AU$1.2b | -AU$374,923,684.00 | 13.6x | -16.4x | 5.1x |
| Sat, 06 Apr 2024 | AU$5.8b | AU$1.2b | -AU$374,923,684.00 | 14.4x | -15.6x | 4.8x |
| Mon, 04 Mar 2024 | AU$5.5b | AU$1.2b | -AU$384,265,496.00 | 13.6x | -14.3x | 4.5x |
| Wed, 31 Jan 2024 | AU$5.8b | AU$896.3m | -AU$589,604,392.00 | 21.2x | -9.8x | 6.5x |
| Fri, 29 Dec 2023 | AU$5.8b | AU$896.3m | -AU$589,604,392.00 | 21.5x | -9.9x | 6.5x |
| Sun, 26 Nov 2023 | AU$4.1b | AU$893.0m | -AU$595,020,018.00 | 17.8x | -6.9x | 4.6x |
| Tue, 24 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 18.6x | -5.9x | 3.9x |
| Thu, 21 Sep 2023 | AU$3.6b | AU$900.3m | -AU$587,952,018.00 | 19.1x | -6.1x | 4x |
| Sat, 19 Aug 2023 | AU$4.1b | AU$1.0b | -AU$626,538,807.00 | 19.4x | -6.5x | 4.1x |
| Mon, 17 Jul 2023 | AU$4.4b | AU$999.0m | -AU$624,794,303.00 | 23.5x | -7x | 4.4x |
| Wed, 14 Jun 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 19.6x | -6.4x | 4x |
| Fri, 12 May 2023 | AU$4.1b | AU$993.2m | -AU$640,306,659.00 | 19.1x | -6.4x | 4.1x |
| Sun, 09 Apr 2023 | AU$4.1b | AU$993.2m | -AU$641,969,868.00 | 17.4x | -6.4x | 4.1x |
| Tue, 07 Mar 2023 | AU$3.6b | AU$1.0b | -AU$671,996,201.00 | 22.8x | -5.4x | 3.6x |
Price to Earnings Ratio
-5.4x
Current Industry PE
- Investors are pessimistic on the Australian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 4.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | 1.08% | |
| Healthcare | -1.77% | |
| Pharma | 0.43% | |
| Pharma | 0.43% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CU6 Clarity Pharmaceuticals | AU$3.61 | 2.8% +AU$37.2m | 1.4% | PS141.9x | |
| NYR Nyrada | AU$0.67 | 14.7% +AU$20.8m | 504.5% | PS68.5x | |
| VLS Vita Life Sciences | AU$2.67 | 4.7% +AU$6.6m | 42.8% | PE14.2x | |
| BOT Botanix Pharmaceuticals | AU$0.056 | -6.7% AU$6.0m | -87.3% | PS21.5x | |
| CAN Cann Group | AU$0.008 | 14.3% +AU$1.6m | -71.9% | PS1x |